REG - CVS Group plc - Block Listing Interim Review

CVSAnnouncement

12/01/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240112:nRSL4644Za&default-theme=true

RNS Number : 4644Z  CVS Group plc  12 January 2024

      12 January 2024

 

CVS Group plc

("CVS" or the "Company")

 

Block Listing Interim Review

CVS, one of the UK's leading providers of integrated veterinary services,
makes the following notification pursuant to Schedule Six of the AIM Rules for
Companies regarding its existing block listing arrangements.  References to
securities are to the Company's ordinary shares of 0.2 pence each ("Ordinary
Shares").

 Name of the company:                                                              CVS Group plc

 Name of relevant scheme:                                                          1.    CVS Group plc 2017-2020 Sharesave Scheme;

                                                                                   2.    CVS Group plc 2018-2021 SAYE Sharesave Scheme; and

                                                                                   3.    CVS Group SAYE Plan

                                                                                   4.    CVS Long Term Incentive Plan 2017

 Period of return:                        From:                                    12 July 2023              To:                       12 January 2024
 Balance of unallotted securities under scheme(s) from previous return:            1.    230

                                                                                   2.    12,864

                                                                                   3.    193,055*

                                                                                   4.    116,296
 Plus: The amount by which the block scheme(s) has been increased since the        1.    Nil
 date of the last return (if any increase has been applied for):

                                                                                   2.    Nil

                                                                                   3.    350,000

                                                                                   4.    60,000
 Less:  Number of securities issued / allotted under scheme(s) during period:      1.    Nil

                                                                                   2.    Nil

                                                                                   3.    150,600

                                                                                   4.    107,903
 Equals: Balance under scheme(s) not yet issued / allotted at end of period:       1.    230

                                                                                   2.    12,864

                                                                                   3.    392,455

                                                                                   4.    68,393
 Number and class of securities originally listed and the date of admission:       1.    114,302 Ordinary Shares admitted on 11 January 2021 and 1,535
                                                                                   Ordinary Shares admitted on 1 September 2021

                                                                                   2.    296,069 Ordinary Shares admitted on 1 September 2021

                                                                                   3.    350,000 Ordinary Shares admitted on 30 December 2021

                                                                                   4.    120,000 Ordinary Shares admitted on 15 May 2023

 

 

*Incorrectly stated as 199,633 in the previous Block Listing Interim Review
announcement on 12 July 2023.

 

The Company currently has ordinary shares of 0.2 pence each block listed under
the following share plans:

 

1.    CVS Group plc 2017-2020 Sharesave Scheme; and

2.    CVS Group plc 2018-2021 SAYE Sharesave Scheme;

All outstanding share awards under the 2017 Sharesave Scheme have now vested
or have lapsed and all outstanding options under the 2018 SAYE Sharesave
Scheme have now been exercised or have lapsed. As a result, the block listings
associated with these share plans have been cancelled and the above consists
of their final block listing return.

 

Contacts:

CVS Group
plc
via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

 

Peel Hunt LLP (Nominated Adviser &
Broker)
+44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

 

   Berenberg (Joint
Broker)
+44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

 

Camarco (Financial
PR)

Geoffrey
Pelham-Lane
                     +44 (0)7733 124 226

Ginny
Pulbrook
+44 (0)7961 315 138

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BLRUASARSRUAAUR